Sergey Deev | Genetics | Best Paper Award

Prof Dr. Sergey Deev | Genetics | Best Paper Award

Member of Russian Academy of Sciences, Member of Academia Europaea, Head of Molecular Immunology Laboratory, Russia

Dr. Sergey M. Deyev is a distinguished Professor and a full member of the Russian Academy of Sciences. Renowned for his contributions to molecular immunology, Dr. Deyev is currently the Deputy Chairman of the Expert Council for Biology at the Russian Foundation for Basic Research and leads the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry. His career spans several decades, characterized by groundbreaking research in targeted cancer therapies and nanoparticle applications.

Profile

Scopus

Education 🎓:

Dr. Deyev completed his M.Sc. in Chemistry from Lomonosov Moscow State University in 1973, followed by a Ph.D. in Molecular Biology from the Engelhardt Institute of Molecular Biology in 1977. His Doctor of Science (D.Sc.) in Molecular Biology was awarded in 1990, with his thesis focusing on the structure and rearrangements of immunoglobulin genes.

Experience 💼:

Dr. Deyev has held prominent roles in academia and research institutions. Since 2000, he has served as the Head of the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute. He also holds professorships at multiple prestigious institutions, including Lomonosov Moscow State University and the National Research Nuclear University “MEPhI.” His extensive experience includes positions as a visiting professor and researcher internationally, furthering his impact in molecular biology and immunology.

Research Interests 🔬:

Dr. Deyev’s research focuses on developing nanotechnology-based solutions for targeted cancer therapies, including using nanoparticles for diagnostic bioimaging and tumor treatment. His lab specializes in the targeted delivery of nano-agents, high-affinity protein complexes, and genetic engineering of recombinant proteins. He is recognized for discovering the barnase-barstar protein pair, which has applications in drug delivery and immunotherapy.

Awards 🏆:

Throughout his career, Dr. Deyev has received numerous honors, including the prestigious “For Merit to the Fatherland” medal in 2018, the Shemyakin Prize in 2016, and the Mechnikov Prize for contributions to immunology and biotechnology. His membership in Academia Europaea and the Russian Academy of Sciences underscores his significant influence in the scientific community.

Publications  Top Notes📚:

Dr. Deyev has co-authored many high-impact research papers, including recent notable publications:

“Flash drug release from nanoparticles accumulated in the targeted blood vessels facilitates the tumour treatment” in Nature Communications (2022) (DOI: 10.1038/s41467-022-34718-3), which has been cited for its contributions to advancing cancer treatment methodologies.

“Switchable targeting of solid tumors by BsCAR T cells” in Proceedings of the National Academy of Sciences USA (2022) (DOI: 10.1073/pnas.2210562119), noted for innovative approaches in T cell-mediated cancer targeting.

Miao Zhu | Genetics | Best Researcher Award

Dr. Miao Zhu | Genetics | Best Researcher Award

attending physician, Yangzhou University, China

🌟 Miao Zhu is a dedicated and accomplished medical professional currently pursuing an M.D. at Yangzhou University’s College of Medicine. With extensive experience in hematology and a strong focus on cancer research, Miao has contributed significantly to the field of tumor biology and Chinese medicine treatment. They have been recognized with numerous awards for their innovative research and clinical excellence.

Publication Profile

Scopus

Strengths for the Award:

  1. Strong Academic Background: Miao Zhu has a solid academic foundation with an M.D. from Yangzhou University and an M.M. from Xuzhou Medical University. His dissertation topics are highly relevant to the medical field, focusing on the inhibition of cancer metastasis and the regulation of tumor-related conditions.
  2. Research Excellence: Zhu’s research is deeply focused on tumor invasion, migration, cytoskeleton, and the application of traditional Chinese medicine in tumor treatment. His involvement in advanced research projects, such as those on gastric cancer and lymphoma, highlights his commitment to addressing critical health issues.
  3. Technical Proficiency: Zhu has mastered a wide range of experimental techniques, from cell culture to complex mouse model experiments. His proficiency in flow cytometry, RNA extraction, PCR, and imaging techniques is particularly impressive and relevant for his research field.
  4. Recognition and Awards: Zhu has been recognized with multiple awards for his research and innovation, including first prizes in provincial competitions and scholarships. His consistent academic and research achievements underscore his potential as a leading researcher.
  5. Publications: Zhu has contributed to several high-impact publications in reputable journals. His work on cancer treatment, particularly involving Chinese medicine, has been published in various journals, demonstrating his ability to contribute valuable insights to the scientific community.

Areas for Improvement:

  1. Broader Collaboration: While Zhu has a strong individual research record, expanding his collaborative efforts with international researchers could further enhance the impact of his work. Collaborative projects can bring diverse perspectives and open up new avenues for research.
  2. Focus on Clinical Applications: While Zhu’s research is highly specialized, emphasizing the direct clinical applications of his findings could strengthen his case for the award. Demonstrating how his research translates into tangible patient outcomes would be beneficial.
  3. Leadership Roles: Gaining experience in leading large-scale research projects or research teams could enhance Zhu’s profile. Leadership in research not only highlights his capabilities but also positions him as a mentor to emerging researchers in the field.

 

Education

🎓 Miao Zhu is currently an M.D. candidate at Yangzhou University’s College of Medicine (2021 – Present), where they are researching the inhibition of gastric cancer metastasis. Miao also holds an M.M. from Xuzhou Medical University (2015 – 2018), where their dissertation explored the effects of Celastrus Orbiculatus Extract and Genistein on inflammatory thrombotic states in lymphoma-bearing mice.

Experience

💼 Miao Zhu has gained valuable clinical experience as a Resident Physician in the Department of Hematology at Subei People’s Hospital (2018 – 2021), mastering internal medicine diagnostics and treatment. They have also honed their research skills at Yangzhou University, participating in key projects and winning prestigious awards.

Research Focus

🔬 Miao Zhu focuses on tumor invasion and migration, cytoskeleton dynamics, tumor cell development and metabolism, and the use of Chinese medicine in tumor treatment. They are proficient in advanced laboratory techniques and have contributed to multiple tumor-related research projects.

Awards and Honors

🏅 Miao Zhu has received numerous accolades, including the First Prize in the 2023 Jiangsu Provincial Inspection Practice Innovation Competition and the Yangzhou New Technology Introduction First Prize in 2023 and 2022. They have also been awarded special scholarships and academic honors for their outstanding contributions.

Publication Highlights

📚 Top Publications:

PTBP1 plays an important role in the development of gastric cancer. Cancer Cell Int 【Cited by 10 articles】. Link.

Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report. Iran J Immunol 【Cited by 5 articles】. Link.

Swollen inguinal lymph nodes with low fever and night sweat: diagnosis and treatment of case of cat-scratch disease lymphadenitis with sinus formation. Heliyon 【Cited by 8 articles】. Link.

Conclusion:

Miao Zhu is a strong candidate for the Research for Best Researcher Award, given his solid academic background, technical proficiency, and significant contributions to cancer research. His work on traditional Chinese medicine in tumor treatment, combined with his recognized achievements, makes him a promising contender. However, expanding his collaborative efforts and focusing on the clinical applications of his research could further solidify his standing as a top researcher in the field.